Biblio Discovery — Demo Discovery Service

47 hasil untuk "Matthias Pinter"

Menampilkan 1–20 · 0,22 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

    Matthias Pinter; Bernhard Scheiner; Markus Peck‐Radosavljevic

    Gut · 2020 · Inggris · OpenAlex Scopus

    Following the success of immune checkpoint blockers (ICBs) in different cancer types, a large number of studies are currently investigating ICBs in patients with hepatocellular carcinoma (HCC), alone or in combination with other treatments. Both nivolumab and pembrolizumab, as well as the…

  2. Artikel Jurnal

    The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma

    Matthias Pinter; Rakesh K. Jain; Dan Gabriel Duda

    JAMA Oncology · 2020 · Inggris · OpenAlex Scopus

    IMPORTANCE: For more than a decade, sorafenib has been the only systemic treatment option for patients with advanced hepatocellular carcinoma (HCC). However, rapid progress over the past few years led to approval of other angiogenesis inhibitors and several immune checkpoint blockers (ICBs) that…

  3. Artikel Jurnal Teks lengkap

    The impact of thyroid hormones on patients with hepatocellular carcinoma

    Matthias Pinter; Lukas Haupt; Florian Hucke dkk.

    PLOS ONE, Vol. 12 No. 8 · 2017 · Inggris · PLOS Scopus

    Background & aims: Hypothyroidism has recently been proposed as predisposing factor for HCC development. However, the role of thyroid hormones (TH) in established HCC is largely unclear. We investigated the impact of TH on clinical characteristics and prognosis of HCC patients. Methods: Of 838…

    Juga tersedia di: DOAJ

  4. Artikel Jurnal Teks lengkap

    Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients

    Lorenz Balcar; David Bauer; Katharina Pomej dkk.

    PLOS ONE, Vol. 18 No. 4 · 2023 · Inggris · PLOS Scopus

    Background & aims: Immunotherapy represents the new standard of care in systemic first-line treatment of hepatocellular carcinoma (HCC). Biomarkers that predict treatment response and survival remain an unmet clinical need. Methods: Patients with HCC treated with immune-checkpoint inhibitors (ICI)…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal Teks lengkap

    C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation

    Tobias Meischl; Susanne Rasoul-Rockenschaub; Georg Györi dkk.

    PLOS ONE, Vol. 14 No. 5 · 2019 · Inggris · PLOS Scopus

    Background: Serum C-reactive protein (CRP) is a prognostic factor for overall survival (OS) and recurrence of hepatocellular carcinoma (HCC) in patients treated with resection or non-surgical treatment. Here, we investigated the association of elevated CRP (≥1 vs.

    Juga tersedia di: DOAJ

  6. Artikel Jurnal Teks lengkap

    COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital

    Katharina Pomej; Bernhard Scheiner; Lukas Hartl dkk.

    PLOS ONE, Vol. 16 No. 8 · 2021 · Inggris · PLOS Scopus

    Background: Patients with hepatocellular carcinoma (HCC) represent a vulnerable population potentially negatively affected by COVID-19-associated reallocation of healthcare resources. Here, we report the impact of COVID-19 on the management of HCC patients in a large tertiary care hospital…

    Juga tersedia di: DOAJ

  7. Artikel Jurnal

    Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion

    Lorenz Balcar; Arpad Mrekva; Bernhard Scheiner dkk.

    Cancer Imaging, Vol. 24 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Background & aims The value of bleeding prophylaxis and anticoagulation in patients with hepatocellular carcinoma (HCC) and macrovascular tumour invasion (MVI) is unclear. We evaluated the impact of anticoagulation on thrombosis progression, bleeding events, and overall mortality, and…

  8. Artikel Jurnal Teks lengkap

    Synthesis and Cytotoxic Activity of Chiral Sulfonamides Based on the 2-Azabicycloalkane Skeleton

    Mahzeiar Samadaei; Matthias Pinter; Daniel Senfter dkk.

    Molecules, Vol. 25 No. 10 · 2020 · Inggris · DOAJ Scopus

    A series of chiral sulfonamides containing the 2-azabicycloalkane scaffold were prepared from aza-Diels–Alder cycloadducts through their conversion to amines based on 2-azanorbornane or the bridged azepane skeleton, followed by the reaction with sulfonyl chlorides. The cytotoxic activity of the…

  9. Artikel Jurnal

    EASL position paper on palliative care in advanced chronic liver disease

    Sumita Verma; Matthias Pinter; Lucia Macken dkk.

    JHEP Reports, Vol. 8 No. 4 · 2026 · Inggris · DOAJ Scopus

    Summary: Deaths from advanced chronic liver disease have increased significantly across Europe, with most affected patients not receiving a liver transplant. Despite this increasing burden, inequities in the provision of palliative care persist. Many patients are referred to specialist palliative…

  10. Artikel Jurnal

    Changing epidemiology and etiology of hepatocellular carcinoma in Europe: implications for clinical practice and health policy

    Bernhard Scheiner; Jeroen Dekervel; Fabio Piscaglia dkk.

    The Lancet Regional Health. Europe, Vol. 70 · 2026 · Inggris · DOAJ Scopus

    Summary: Primary liver cancer, of which hepatocellular carcinoma (HCC) represents the vast majority, is on the rise globally. Despite an expected decrease in viral hepatitis-related HCCs, the number of new cases and deaths from liver cancer is predicted to increase by over 30% in 2050 in Europe…

  11. Artikel Jurnal

    Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma

    Kristina Breitenecker; Viola Hedrich; Franziska Pupp dkk.

    Frontiers in Oncology, Vol. 13 · 2023 · Inggris · DOAJ Scopus

    IntroductionHepatocellular carcinoma (HCC) patients at advanced stages receive immunotherapy or treatment with tyrosine kinase inhibitors (TKIs) such as Sorafenib (Sora) or Lenvatinib in frontline as well as Regorafenib (Rego) or Cabozantinib in second-line. A major hindrance of TKI therapies is…

  12. Artikel Jurnal Teks lengkap

    Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study

    Katharina Pomej; Adrian Frick; Bernhard Scheiner dkk.

    PLOS ONE, Vol. 20 No. 4 · 2025 · Inggris · PLOS Scopus

    Background: The gut microbiota is often altered in chronic liver diseases and hepatocellular carcinoma (HCC), and increasing evidence suggests that it may influence response to cancer immunotherapy. Strategies to modulate the gut microbiome (i.e., fecal microbiota transplant (FMT)) may help to…

  13. Artikel Jurnal Teks lengkap

    Optimizing Imaging Parameters for Assessment of Hepatocellular Carcinoma Using Photon-Counting Detector Computed Tomography—Impact of Reconstruction Kernel and Slice Thickness

    Anna Szelenyi; Philipp Stelzer; Christian Wassipaul dkk.

    Tomography, Vol. 11 No. 7 · 2025 · Inggris · DOAJ Scopus

    Background: The use of photon-counting detector computed tomography (PCD-CT) has improved image quality in cardiac, pulmonary, and musculoskeletal imaging. Abdominal imaging research, especially about the use of PCD-CT in hepatocellular carcinoma (HCC), is sparse. Objectives: We aimed to compare…

  14. Artikel Jurnal

    Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials

    Claudia Angela Maria Fulgenzi; Bernhard Scheiner; James Korolewicz dkk.

    JHEP Reports, Vol. 5 No. 5 · 2023 · Inggris · DOAJ Scopus

    Background & Aims: Direct comparisons across first-line regimens for advanced hepatocellular carcinoma are not available. We performed a network metanalysis of phase III of trials to compare first-line systemic treatments for hepatocellular carcinoma in terms of overall survival (OS)…

  15. Artikel Jurnal

    Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease

    Lorenz Balcar; Julia Krawanja; Bernhard Scheiner dkk.

    JHEP Reports, Vol. 5 No. 4 · 2023 · Inggris · DOAJ Scopus

    Background & Aims: Ammonia levels predicted hospitalisation in a recent landmark study not accounting for portal hypertension and systemic inflammation severity. We investigated (i) the prognostic value of venous ammonia levels (outcome cohort) for liver-related outcomes while accounting for these…

  16. Artikel Jurnal

    COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality

    Lukas Hartl; Georg Semmler; Benedikt Silvester Hofer dkk.

    Hepatology Communications, Vol. 5 No. 10 · 2021 · Inggris · DOAJ Scopus

    The coronavirus disease 2019 (COVID‐19) pandemic necessitated down‐scaling of in‐hospital care to prohibit the spread of severe acute respiratory syndrome–coronavirus‐2. We (1) assessed patient perceptions on quality of care by telesurvey (cohort 1) and written questionnaire (cohort 2), and (2)…